Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530234 | SCV000648260 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002269287 | SCV002553176 | uncertain significance | not provided | 2022-01-20 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV004024141 | SCV003531923 | uncertain significance | Cardiovascular phenotype | 2023-05-22 | criteria provided, single submitter | clinical testing | The p.R1422Q variant (also known as c.4265G>A), located in coding exon 28 of the MYH6 gene, results from a G to A substitution at nucleotide position 4265. The arginine at codon 1422 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV002269287 | SCV005211365 | likely benign | not provided | criteria provided, single submitter | not provided |